Africa’s First CoC Registry Goes Live for SA’s 20 September Trade Deadline 
Santamarina + Steta Strengthens Its Tax Practice with the Addition of Luis Curiel Pina and Francisco Carbajal Dominguez 
Berry AI and Culver’s Announce Brand-Wide Vision AI Deployment Across 1,000+ Restaurants 
Sensiba Names Monic Ramirez as Managing Partner Amid Firm-Wide Transformation TRIPLE PLAY 2021: The Real Estate Convention Stages a Comeback
NRIA calls Triple Play “a success,” says attendees valued face-to-face connections SECAUCUS, NJ / ACCESSWIRE…
Coro Cyber Security Platform Ranked #1 in Implementation and Usability in G2’s Winter 2022 Grid® Report on Cloud Security Monitoring and Analytics
Coro also ranked #1 for Implementation in G2’s Winter 2022 Grid® Report on Cloud Data…
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration…
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
There are no currently approved therapies impacting disease progression for the up to 8 million…
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Submission is supported by comprehensive package of analytical, pre-clinical and clinical data, proposed biosimilar trastuzumab…
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities
VYRA™ CoV2Flu Rapid Antigen Rapid Test. VYRA™ CoV2Flu Rapid Antigen Rapid Test. HALIFAX, Nova Scotia,…
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the…
Histogen Announces Closing of $3.5 Million Private Placement
SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company…
XORTX Reports Annual & Special Meeting Results
CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
Nabriva Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
DUBLIN, Ireland and FORT WASHINGTON, Pa., Dec. 21, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
Aligos Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Oyster Point Pharma to Present at Upcoming Investor Conferences in January 2022
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Sanofi: Information concerning the total number of voting rights and shares – NOVEMBER 2021
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate
Saint Herblain (France), December 21, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska
Endorsement Applies to: Tauri-Gum™ Product Line New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) —…
OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer
In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine NANTES, France, Dec….
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating…
Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships
Dr. Trilla’s 30-Year Career as a Life Science and Business Entrepreneur Provides Unique Value to…
Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication
Editor-in-Chief States: “After Careful Examination of These Original Material, Neuroscience [Journal] Found No Evidence of…
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO) Michelle McMurry-Heath Joins Bioventus…